Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.
Loscher says there’s no evidence to suggest that a flu jab wouldn't last the entire season and this is why we don’t get a flu ...
The HANNspree Lumo tablet pairs a reflective, paper-like display with full Android 14, to offer an alternative that's easy on ...